"10.1371_journal.pone.0078538","plos one","2013-10-25T00:00:00Z","Amelie Pielen; Nicolas Feltgen; Christin Isserstedt; Josep Callizo; Bernd Junker; Christine Schmucker","University Eye Hospital, Albert Ludwig University, Freiburg, Germany; University Eye Hospital, Medical School of Hannover, Hannover, Germany; University Eye Hospital, Georg-August-University, Goettingen, Germany; German Cochrane Centre, Institute of Medical Biometry and Medical Informatics, Department of Medical Biometry and Statistics, University Medical Centre, Freiburg, Freiburg, Germany","Conceived and designed the experiments: AP NF CI CS. Performed the experiments: AP NF CI JC BJ CS. Analyzed the data: AP NF CI JC BJ CS. Contributed reagents/materials/analysis tools: AP NF CI JC BJ CS. Wrote the manuscript: AP NF CI JC BJ CS.","The authors have the following interests. Amelie Pielen is consultant for Allergan, Bayer HealthCare and Novartis Pharma, investigator in multicenter clinical trials sponsored by Bayer HealthCare, Novartis Pharma, GlaxoSmithKline, Pfizer, Alcon, Accovion and Genentech, received research grants from Novartis Pharma and travel grants from Bayer HealthCare. Nicolas Feltgen is consultant for Bayer, Novartis and Allergan, investigator in clinical trials sponsored by Bayer, Novartis and Allergan and received research and travel grants from Novartis. Josep Callizo is consultant for Bayer, Allergan and Novartis, investigator in clinical trials sponsored by Bayer, Allergan and Novartis and received travel grant from Novartis. Bernd Junker is investigator in multicenter clinical trials sponsored by Bayer HealthCare, Novartis Pharma, GlaxoSmithKline, Pfizer, Alcon, Accovion and Genentech and functioned as lecturer for Heidelberg Engeneering, Allergan and Novartis. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2013","10","Amelie Pielen","AP",6,TRUE,4,6,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
